IL234689A0 - A combined treatment that includes sulfated glycosaminoglycans to induce labor - Google Patents

A combined treatment that includes sulfated glycosaminoglycans to induce labor

Info

Publication number
IL234689A0
IL234689A0 IL234689A IL23468914A IL234689A0 IL 234689 A0 IL234689 A0 IL 234689A0 IL 234689 A IL234689 A IL 234689A IL 23468914 A IL23468914 A IL 23468914A IL 234689 A0 IL234689 A0 IL 234689A0
Authority
IL
Israel
Prior art keywords
combination treatment
inducing labor
sulphated glycosaminoglycans
sulphated
glycosaminoglycans
Prior art date
Application number
IL234689A
Other languages
English (en)
Hebrew (he)
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilafor Ab filed Critical Dilafor Ab
Publication of IL234689A0 publication Critical patent/IL234689A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL234689A 2012-03-26 2014-09-16 A combined treatment that includes sulfated glycosaminoglycans to induce labor IL234689A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261615398P 2012-03-26 2012-03-26
PCT/SE2013/050332 WO2013147689A1 (en) 2012-03-26 2013-03-25 Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Publications (1)

Publication Number Publication Date
IL234689A0 true IL234689A0 (en) 2014-11-30

Family

ID=49260783

Family Applications (1)

Application Number Title Priority Date Filing Date
IL234689A IL234689A0 (en) 2012-03-26 2014-09-16 A combined treatment that includes sulfated glycosaminoglycans to induce labor

Country Status (15)

Country Link
US (1) US20150045322A1 (enExample)
EP (1) EP2830635A4 (enExample)
JP (1) JP6234989B2 (enExample)
CN (1) CN104203256B (enExample)
AU (1) AU2013240597A1 (enExample)
CA (1) CA2868444A1 (enExample)
HK (1) HK1203369A1 (enExample)
IL (1) IL234689A0 (enExample)
MX (1) MX2014011505A (enExample)
MY (1) MY175743A (enExample)
RU (1) RU2014143017A (enExample)
SG (1) SG11201406119WA (enExample)
UA (1) UA117908C2 (enExample)
WO (1) WO2013147689A1 (enExample)
ZA (1) ZA201406901B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2794665T3 (da) 2011-12-19 2018-01-29 Dilafor Ab Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
US20150099703A1 (en) * 2012-05-08 2015-04-09 Dilafor Ab Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
US12502403B2 (en) 2020-02-17 2025-12-23 Dilafor Ab Tafoxiparin for the treatment of preeclampsia
CA3255831A1 (en) 2022-05-03 2023-11-09 Dilafor Ab NEW MEDICAL USE OF TAFOXIPARIN
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5993810A (en) * 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US8445436B2 (en) * 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
WO2013081896A1 (en) * 2011-11-28 2013-06-06 Corning Incorporated Robust optical touch-screen systems and methods using a planar transparent sheet
DK2794665T3 (da) * 2011-12-19 2018-01-29 Dilafor Ab Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf

Also Published As

Publication number Publication date
JP2015511664A (ja) 2015-04-20
WO2013147689A1 (en) 2013-10-03
JP6234989B2 (ja) 2017-11-22
UA117908C2 (uk) 2018-10-25
MY175743A (en) 2020-07-07
CN104203256A (zh) 2014-12-10
MX2014011505A (es) 2014-12-05
CA2868444A1 (en) 2013-10-03
US20150045322A1 (en) 2015-02-12
HK1203369A1 (en) 2015-10-30
CN104203256B (zh) 2017-11-24
SG11201406119WA (en) 2014-11-27
RU2014143017A (ru) 2016-05-20
AU2013240597A1 (en) 2014-10-16
EP2830635A4 (en) 2016-03-16
EP2830635A1 (en) 2015-02-04
ZA201406901B (en) 2017-09-27

Similar Documents

Publication Publication Date Title
EP2787497A4 (en) DEFAULT ASSESSMENT APPARATUS
EP2815691A4 (en) ENDOSCOPE
EP2692278A4 (en) Borescope
EP2891448A4 (en) ENDOSCOPE
EP2820999A4 (en) ENDOSCOPE
EP2837320A4 (en) Borescope
GB201218666D0 (en) Apparatus
EP2835093A4 (en) ENDOSCOPE
EP2868252A4 (en) Borescope
EP2856924A4 (en) Borescope
GB201220673D0 (en) Apparatus
EP2865318A4 (en) ENDOSCOPE
GB201219738D0 (en) Apparatus
GB201212900D0 (en) Triage scoring system
ZA201406901B (en) Combination treatment comprising sulphated glycosaminoglycans for inducing labor
ZA201501562B (en) Treatment regimens
EP2889035A4 (en) Anti-tumor agent
IL217807A0 (en) Therapeutic compositions
GB201215796D0 (en) Apparatus
GB201204981D0 (en) Pre-harvest treatment
EP2822545A4 (en) TREATMENT OF HIGH RATE OF CHOLESTEROL
GB201201805D0 (en) Speculum
GB2503675B (en) Brackets
GB2498997B (en) Oven cleaning system
GB201211135D0 (en) Treatment